The Prescription Drug Pricing Game: Who’s Making Money Off Your Medicine?

Sharx Logo

Why does a prescription medication cost $5 at one pharmacy, $14 at another, and more than $20 at a third? And why can paying cash sometimes be cheaper than using your health insurance?

Those are just a few of the frustrating questions Mark Alyn explores in this revealing edition of Late Night Health with Paul Pruitt, co-founder of SHARx, a company helping employers and their employees navigate the complicated world of high-cost prescription medications.

The conversation begins with Medicare Part D, where confusing coverage options, changing insurance plans, and wildly different pharmacy prices can leave consumers wondering whether they’re getting a fair deal. Mark shares his own experience comparing prescription prices at CVS, a local pharmacy, and Mark Cuban’s Cost Plus Drugs—and discovering significant differences for the same generic medication.

But the discussion quickly moves beyond everyday prescriptions.

Pruitt reveals that medications for his two sons cost approximately $2.7 million annually—an astonishing example of the financial burden associated with treating rare diseases. For patients requiring specialized medications, the stakes can be far greater than saving a few dollars on a monthly prescription.

Mark and Paul examine the role of pharmacy benefit managers, commonly known as PBMs, and how these powerful intermediaries influence prescription pricing. They also discuss the consolidation of pharmacies and insurance companies, the decline of personalized pharmacy service, and whether competition and greater price transparency could help consumers.

The conversation also explores the potential implications of a proposed CVS corporate restructuring and why Pruitt believes patients may see little immediate difference.

SHARx takes a different approach by working with employers to help employees obtain expensive medications through more affordable options while continuing necessary treatment. Pruitt explains why the company focuses on the costly specialty drugs that account for a disproportionate share of prescription spending.

Can the American prescription drug system become more affordable, transparent, and compassionate?

It’s a candid, sometimes surprising conversation about an issue affecting families, employers, and anyone who has ever stood at a pharmacy counter wondering why their medicine costs so much.

Listen to Late Night Health with Mark Alyn and discover why shopping around for prescriptions may be more important than ever

Leave a Reply

Your email address will not be published. Required fields are marked *